In summary, our current results revealed that SHP-1 significantly inhibits breast cancer cell proliferation and cell invasion and suppresses mammary tumorigenesis in xenografts in mice by directly interacting with EGFR and inhibiting the EGFR/Ras/Erk/GSK3β signaling pathway. This evidence concerns the gene GSK3B and breast carcinoma.